Kimia Farma Tbk PT banner

Kimia Farma Tbk PT
IDX:KAEF

Watchlist Manager
Kimia Farma Tbk PT Logo
Kimia Farma Tbk PT
IDX:KAEF
Watchlist
Price: 468 IDR Market Closed
Market Cap: Rp2.6T

Kimia Farma Tbk PT
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Kimia Farma Tbk PT
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Kimia Farma Tbk PT
IDX:KAEF
Inventory
Rp1.4T
CAGR 3-Years
-20%
CAGR 5-Years
-14%
CAGR 10-Years
6%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Inventory
Rp2.3T
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
7%
Kalbe Farma Tbk PT
IDX:KLBF
Inventory
Rp7T
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
9%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Inventory
Rp483.5B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
8%
Soho Global Health Tbk PT
IDX:SOHO
Inventory
Rp1.6T
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Inventory
Rp492.1B
CAGR 3-Years
36%
CAGR 5-Years
54%
CAGR 10-Years
29%
No Stocks Found

Kimia Farma Tbk PT
Glance View

Market Cap
2.6T IDR
Industry
Pharmaceuticals

PT Kimia Farma Tbk engages in the production and distribution of healthcare products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 11,668 full-time employees. The company went IPO on 2001-07-04. The firm produces medical devices and chemical materials. The firm is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.

KAEF Intrinsic Value
1 081.25 IDR
Undervaluation 57%
Intrinsic Value
Price

See Also

What is Kimia Farma Tbk PT's Inventory?
Inventory
1.4T IDR

Based on the financial report for Sep 30, 2025, Kimia Farma Tbk PT's Inventory amounts to 1.4T IDR.

What is Kimia Farma Tbk PT's Inventory growth rate?
Inventory CAGR 10Y
6%

Over the last year, the Inventory growth was -29%. The average annual Inventory growth rates for Kimia Farma Tbk PT have been -20% over the past three years , -14% over the past five years , and 6% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett